Relay Therapeutics, Inc. (RLAY) shares outstanding

Shares outstanding · fiscal 2025
171.59M

Relay Therapeutics, Inc. (RLAY) had 171.59M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 20.1% higher than the 142.87M of fiscal 2024. Figures as of 18 Nov 2026, 11:52 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
171.59M
Change on fiscal 2024
+20.1%
Growth, 5 years
+32.1% a year
Highest on record
171.59Mfiscal 2025
Lowest on record
42.62Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Relay Therapeutics, Inc. shares outstanding, in more detail

The market data feed counts 220.96M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 32.1% a year. Across the 6 fiscal years on record (2020–2025), the highest was 171.59M in fiscal 2025 and the lowest 42.62M in fiscal 2020.

History · 6 fiscal years

Shares outstanding by fiscal year

Relay Therapeutics, Inc. shares outstanding, year by year

Relay Therapeutics, Inc. (RLAY) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025171.59M 20.1% up
2024142.87M 16.6% up
2023122.58M 9.2% up
2022112.23M 18.0% up
202195.14M 123.2% up
202042.62M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on RLAY

Relay Therapeutics, Inc., figure by figure

Relay Therapeutics, Inc. (RLAY) overview: price, valuation and scorecard

Relay Therapeutics, Inc. shares outstanding: questions and answers

How many shares does Relay Therapeutics, Inc. have?

Relay Therapeutics, Inc. (RLAY) had 171.59M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 20.1% higher than the 142.87M of fiscal 2024. The market data feed counts 220.96M shares outstanding today.

What is the growth rate of Relay Therapeutics, Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 32.1% a year.

What are the highest and lowest diluted share count figures on record for Relay Therapeutics, Inc.?

Across the 6 fiscal years on record (2020–2025), the highest was 171.59M in fiscal 2025 and the lowest 42.62M in fiscal 2020.

How is Relay Therapeutics, Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Relay Therapeutics, Inc. it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Relay Therapeutics, Inc. (RLAY) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/RLAY/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.